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Abstract. Ezrin is a component of the microvillus cyto- 
skeleton of a variety of polarized epithelial cells and is 
believed to function as a membrane-cytoskeletal 
linker. In this study, we isolated microvilli from human 
placental syncytiotrophoblast as a model system for 
biochemical analysis of ezrin function. In contrast to in- 
testinal microvilli, ezrin is a major protein component 
of placental microvilli, comprising ~5 % of the total 
protein mass and present at about one quarter of the 
molar abundance of actin. Gel filtration and chemical 
cross-linking studies demonstrated that ezrin exists 
mainly in the form of noncovalent dimers and higher 
order oligomers in extracts of placental microvilli. A 
novel form of ezrin, apparently representing covalently 
cross-linked adducts, was present as a relatively minor 
constituent of placental microvilli. Both oligomers and 
adducts remained associated with the detergent-insolu- 
ble cytoskeleton, indicating a tight interaction with ac- 
tin filaments. Moreover, stimulation of human A431 
carcinoma cells with EGF induces the rapid formation 
of ezrin oligomers in vivo, thus identifying a signal 
transduction pathway involving ezrin oligomerization 
coincident with microvillus assembly. In addition to 
time course studies, experiments with tyrosine kinase 
and tyrosine phosphatase inhibitors revealed a correla- 
tion between the phosphorylation of ezrin on tyrosine 
and the onset of oligomer formation, consistent with 
the possibility that phosphorylation of ezrin might be 
required for the generation of stable oligomers. Based 
on these observations, a model for the assembly of cell 
surface structures is proposed. 
ZRIN was identified over twelve years ago as a minor 
component of the isolated intestinal microvillus cy- 
toskeleton (Bretscher,  1983),  and has since  been 
found in the apical microvilli of a wide variety of polarized 
epithelial cell types within the body (Hanzel et al., 1991; 
Wolf  et  al.,  1991; Berryman  et  al.,  1993; Hofer  and 
Drenckhahn, 1993), in the microvilli and other actin-rich 
surface structures of cultured cells (Bretscher, 1983, 1989; 
Gould et al., 1986; Pakkanen, 1988; Pakkanen et al., 1987, 
1988; Sato et al.,  1992; Franck et al., 1993; Soroka et al., 
1993; Algrain et al., 1993; Shuster and Herman, 1995; Mar- 
tin et al., 1995), and in the marginal band of chicken eryth- 
rocytes (Winckler et al., 1994). 
Several lines of evidence indicate that ezrin attaches mi- 
crofilaments to the plasma membrane. Ezrin contains an 
NH2-terminal domain that shares 37%  sequence identity 
with the corresponding region of band 4.1  (Gould et al., 
1989).  This  domain of band 4.1  associates with integral 
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membrane proteins of the erythrocyte plasma membrane 
to mediate cytoskeletal linkages (Anderson and Lovrien, 
1984;  Anderson  and  Marchesi,  1985; Pasternack  et  al., 
1985; Leto et al., 1986; Marfatia et al., 1994). Support for a 
membrane-cytoskeletal linking function for ezrin includes 
immunoelectron  microscopy,  which  has  revealed  that 
ezrin  is  closely and  specifically associated with  the  mi- 
crovillus plasma membrane in several epithelial cell types 
(Berryman et al.,  1993).  Moreover, Algrain et al. (1993) 
have shown that the COOH- and NH2-terminal halves of 
ezrin  associate  with the  cytoskeleton and  plasma  mem- 
brane, respectively. Complexes containing ezrin and CD44, 
a polymorphic integral membrane protein which binds to 
extracellular matrix proteins, have been isolated from cul- 
tured  cells  by  co-immunoprecipitation  (Tsukita  et  al., 
1994). Finally, two laboratories have identified an F-actin 
binding site in the COOH-terminal tail of ezrin (Turunen 
et al., 1994; Pestonjamasp et al., 1995), a domain which ap- 
pears to be masked in the native ezrin molecule (Gary and 
Bretscher, 1995). 
Radixin and moesin are two independently discovered 
proteins that share 75 % sequence identity with ezrin over 
the entire length of the coding region (Funayama et al., 
1991; Lankes and Furthmayr, 1991). Together, these pro- 
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family (Sato et al.,  1992).  Structural analysis, localization 
studies,  and  evolutionary considerations  suggest  related 
but  distinct  functions  for  ezrin,  radixin,  and  moesin 
(Gould et al., 1989; Funayama et al., 1991; Sato et al., 1992; 
Berryman  et  al.,  1993;  Franck  et  al.,  1993;  Gary  and 
Bretscher, 1993; Lankes et al.,  1993; Amieva et al.,  1994; 
Takeuchi et al., 1994a,b; Tsukita et al.,  1994; Winckler et 
al.,  1994; Pestonjamasp et al.,  1995).  Although ERM pro- 
teins are coexpressed in many cultured cell lines (Sato et 
al., 1992), their pattern of expression in the body is mainly 
cell-type specific (Berryman et al.,  1993;  Amieva et  al., 
1994).  Depletion of ERM proteins by antisense oligonu- 
cleotides has provided direct evidence for their role in de- 
termining cell surface morphology (Takeuchi et al., 1994a). 
In addition, ERM-related molecules which appear to play 
a  role in  cell morphology have  been  identified in Dro- 
sophila (Ibnsouda et al., 1993; Edwards et al., 1994) and in 
the sea urchin Lytechinus variegatus (Bachman and Mc- 
Clay, 1995). An intriguing property of ERM family mem- 
bers is their ability to associate in a homotypic or hetero- 
typic fashion both in vivo and in vitro (Gary and Bretscher, 
1993; Andreoli et al.,  1994).  These interactions appear to 
involve exclusively complementary binding  of two  non- 
overlapping NH2- and COOH-terminal domains, termed 
N- and C-ERMADs (ezrin-radixin-moesin association do- 
main), respectively. The C-ERMAD, which encompasses 
the entire F-actin binding site, is masked in native ezrin in 
solution, suggesting that F-actin binding as well as hetero- 
or homotypic ERM associations might be regulated through 
unmasking of this domain (Gary and Bretscher, 1995). 
A correlation between the phosphorylation of ezrin and 
changes in cell morphology has been demonstrated in sev- 
eral systems. There exists a close temporal relationship be- 
tween the phosphorylation of ezrin on tyrosine residues 
and the rapid formation of microvilli and membrane ruf- 
fles enriched in both actin and  ezrin in EGF-stimulated 
A431 cells (Bretscher, 1989). Ezrin also becomes phospho- 
rylated on tyrosine in many other systems (Kamps et al., 
1986; Krieg and Hunter, 1992; Hansen and Moeller, 1993; 
Fazioli et al.,  1993;  Egerton et  al.,  1992;  Thuiller et  al., 
1994). Stimulation of gastric parietal cells with agents that 
elevate cAMP levels induces the phosphorylation of ezrin 
on serine and threonine residues concomitant with the ap- 
pearance of microvilli rich in ezrin (Urushidani et al., 1989; 
Hanzel et al., 1989, 1991). 
Although ezrin purified from intestinal microvilli (Bret- 
scher,  1983)  and  cultured  human  choriocarcinoma cells 
(Narvanan, 1985) was originally characterized as a mono- 
meric protein in solution, subsequent studies suggested the 
existence of oligomeric species as well (Pakkanen and Va- 
heri, 1989; Ullrich et al.,  1986).  We recently reported the 
purification from human placenta of two stable forms of 
ezrin that do not readily interconvert in vitro. Chemical 
and physical characterization revealed that they are com- 
posed of ezrin monomers and elongated dimers (Bretscher 
et al.,  1996).  Here we show that ezrin is a major compo- 
nent of isolated placental microvilli where it is cytoskele- 
1.  Abbreviations  used  in  this paper:  DSP,  dithiobis-succinimidyl-propi- 
onate; ERM, ezrin-radixin-moesin; ERMAD, ezrin, radixin, moesin asso- 
ciation domain; PVDF, polyvinylidene fluoride. 
tally associated  and  exists primarily in  oligomeric form. 
We also document the rapid formation of ezrin oligomers 
with tyrosine phosphorylation of ezrin in EGF-stimulated 
A431 cells. Since these growth factor-induced biochemical 
events coincide with the appearance of newly formed mi- 
crovilli and membrane ruffles (Bretscher, 1989), it is possi- 
ble that ezrin oligomerization plays an important role in 
the biogenesis of these structures and in the development 
of epithelial cell polarity. Based on these results, we pro- 
pose  a  speculative  model  for the  involvement of ERM 
proteins in the assembly of cell surface structures. 
Materials and Methods 
Materials 
Ezrin was purified from human placenta (Bretscher, 1989), obtained from 
consenting patients at Tompkins Community Hospital (Ithaca, NY). Af- 
finity-purified rabbit anti-human ezrin antibodies that do not recognize 
moesin or radixin have been described (Franck et al., 1993). Mouse mono- 
clonal anti-ezrin antibody Z036, raised against a  synthetic peptide cor- 
responding  to  the  COOH-terminal  10  residues  of  human  ezrin,  was 
purchased from Zymed Laboratories, Inc. (South San Francisco, CA). Af- 
finity-purified rabbit anti-radixin antibody, raised against a synthetic pep- 
tide corresponding to residues 502-509 of mouse radixin (Fazioli et al., 
1993), was a generous gift from Dr. Di Fiore and Dr. Wong (National In- 
stitutes of Health, Bethesda, MD). 
Preparation of Microvilli 
Microvilli were  prepared  from fresh placental tissue essentially as  de- 
scribed by Booth et al. (1980). All steps were performed at 4°C. The um- 
bilical cord and membranes were removed, and the placenta was cut into 
20--30 g pieces. After rinsing the pieces briefly in 0.15 M NaCI (saline) to 
remove excess blood, the tissue was minced and stirred in 500-600 ml sa- 
line for  1 h. The material was passed through a  nylon sieve (1,000 Ixm 
mesh) and the filtrate was centrifuged 10,000 g for 10 min. The superna- 
tant  was  then  centrifuged  90,000  g  for  30  min.  Using a  loose-fitting 
Dounce, this pellet was resuspended in 50 ml of 10 mM mannitol, 2 mM 
Tris, pH 7.1,  1 mM PMSF, and 0.5 mM benzamidine. Solid MgCI2.6H20 
was added to 10 mM final concentration and the suspension was stirred 
for 15 min, followed by centrifugation at 5,000 g for 10 min. The superna- 
tant was centrifuged 20,000 g for 30 min to pellet the microvilli. Microvilli 
were washed by gentle resuspension in saline and recentrifugation. Fi- 
nally, microvilli were resuspended at 1-2 mg protein/ml in saline contain- 
ing 0.02% sodium azide, and either used immediately or stored on ice. 
Electron Microscopy 
Freshly isolated microvilli were  prepared  for conventional thin section 
analysis by initial fixation in suspension with addition of an equal volume 
of 4% glutaraldehyde, 4% formaldehyde, and 2% tannic acid in PBS, pH 
7.0. After centrifugation, the pellet was post-fixed with 2% osmium tetrox- 
ide, dehydrated in ethanol, and embedded in Epon. Ultrathin sections were 
stained with uranyl acetate and lead citrate. 
For immunoelectron microscopy, intact pieces of fresh placenta tissue 
were processed as previously described (Berryman et al., 1993).  Isolated 
microvilli were  fixed in suspension by addition  of an equal  volume of 
0.5%  glutaraldehyde and 2%  formaldehyde in PBS, pH 7.4.  Following 
centrifugation, the pellet was treated with 50 mM ammonium chloride, 
post-fixed with 1% uranyl acetate, dehydrated in ethanol, and embedded 
in  LR  Gold  resin  as  described  previously  (Berryman  and  Rodewald, 
1990).  Sections were stained with 2 Ixg/ml affinity-purified ezrin antibody, 
followed by 5-nm colloidal gold-labeled secondary antibodies. Specimens 
were  examined at  60 kV in  a  Philips 301  electron microscope  (Philips 
Electronic Instruments Inc., Mahawah, N J). 
Immunodepletion and Immunoprecipitation 
Microvilli (0.5 mg protein) were pelleted by centrifugation, and then ex- 
tracted by resuspension in 1 ml ice-cold RIPA buffer: 0.1% SDS, 1% Tri- 
ton X-100, 1% deoxycholate, 0.15 M NaCI, 2 mM EDTA, 25 mM Tris, pH 
7.4,  1 Ixg/ml leupeptin, 1 ~g/ml pepstatin A,  1 mM PMSF, and 0.5 mM 
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20 min. The insoluble pellet was resuspended to the same volume as the 
supernatant and aliquots of these fractions were boiled in Laemmli sam- 
ple buffer under reducing conditions. Immunodepletion of ezrin was per- 
formed by incubation of 400 ixl of soluble extract with 15 ixl of ezrin anti- 
serum that had been pre-adsorbed to 25 p.l protein A-Sepharose beads 
(Sigma Chemical Co., St. Louis, MO). Quantitative removal of ezrin was 
accomplished by two sequential incubations with the immunobeads. The 
immunoprecipitates were washed, eluted by boiling in Laemmli sample 
buffer, and then pooled. 
Preparation of Cytoskeletons 
Microvilli in suspension (2 mg/ml) were extracted for 15 min at room tem- 
perature by addition of an equal volume of 2% Triton X-100, 75 mM KC1, 
10 mM Hepes, pH 7.4, I mM DTF, 1 mM EGTA, 2 mM PMSF, and i  mM 
benzamidine. The extract was centrifuged 20,000 g for 15 min to pellet the 
cytoskeletons. The pellet  was washed by gentle resuspension in buffer 
containing 0.1%  Triton X-100 and then recentrifuged.  In some experi- 
ments, washed cytoskeletons were resuspended in various extraction buff- 
ers, centrifuged, and equal volumes of the soluble and insoluble fractions 
analyzed on stained gels and by Western blots. 
Western Blots, Blot Overlay, and Lectin Blot 
Proteins were resolved by SDS-PAGE (Laemmli, 1970),  and then trans- 
ferred to Immobilon polyvinylidene fluoride (PVDF) membranes (Milli- 
pore  Corp.,  Bedford,  MA)  using a  semi-dry electroblotter  (Integrated 
Separation Systems, Hyde Park, MA). 
Western blots were blocked with 10% nonfat dry milk, and probed di- 
rectly  with 0.1  ixg/ml peroxidase-conjugated anti-phosphotyrosine anti- 
body (Transduction Laboratories, Lexington, KY), or probed with 0.1 ~Lg/ 
ml ezrin  antibody  followed  by  60  ng/ml protein  A-peroxidase  (Sigma 
Chem. Co.). 
Biotinylated ezrin was prepared and blot overlays were performed ac- 
cording to the method of Gary and Bretscher (1993). For control blots, ei- 
ther the biotinyl-ezrin probe was omitted or a 10-fold excess of unlabeled 
purified human ezrin was mixed with the biotinyl-ezrin to compete for 
specific ezrin binding sites on the PVDF membrane. 
For lectin blots, membranes were blocked with 3% BSA, 0.5 M NaCl, 
10% Tween-20, 0.05 M  Tris, pH 8.0. Blots were probed directly with 0.5 
ixg/ml peroxidase-conjugated concanavalin A  (Sigma Chemical Co.)  in 
blocking buffer containing 0.3% BSA. 
All  blots  were  developed  by  enhanced chemiluminescence (Amer- 
sham,  Arlington  Heights,  IL).  In  some  experiments,  the  blots  were 
stripped according to the manufacturer's instructions, and then reprobed 
with other reagents. 
Cell Culture and EGF Treatment 
A431 (human epidermoid carcinoma) cells were obtained from the Amer- 
ican Type Culture ColLection (Rockville, MD) and cultured in Dulbecco's 
modified Eagle's medium supplemented with 10% fetal bovine serum and 
antibiotics. Cells were grown to near confluence in 100-mm dishes and 
then incubated in serum-free medium for 10 h before treatment at 37°C 
with 100 ng/ml EGF (Upstate Biotechnology Inc., Lake Placid, NY) for 
various  times.  Next,  cells  were  rinsed  briefly  with  ice-cold  PBS  and 
scraped into the appropriate extraction buffer. Following brief trituration, 
the extracts were clarified by centrifugation at 100,000 g for 20 min, and 
then subjected to gel filtration chromatography or chemical cross-linking, 
as described below. 
In some experiments, cells were treated with the indicated concentra- 
tions of tyrphostin AG1478 (Calbiochem-Novabiochem Corp., San Diego, 
CA) or phenylarsine oxide (Aldrich Chem. Co., Milwaukee, WI) in di- 
methyl sulfoxide during the last 3 h or 30 min, respectively, of serum star- 
vation and during stimulation with EGF.  Control  cells were  incubated 
with dimethyl sulfoxide alone. 
Gel Filtration  Chromatography  and Quantitation 
Placental microvilli were extracted for 10 min on ice with 1% Triton X-100, 
0.6 M KC1, 10 mM Hepes, pH 7.4,  1 mM EDTA, and protease inhibitors, 
and then were  centrifuged 100,000  g  for 20 min. The  supernatant was 
loaded onto a Superose 6 HR 10/30  (Pharmacia Fine Chemicals, Piscat- 
away, NJ) gel filtration column equilibrated with 10 mM Hepes, 100 mM 
NaC1,  1 mM EDTA, pH 7.4, at a flow rate of 0.2 ml/min; 0.5 ml fractions 
were collected. The column was calibrated under identical conditions with 
conventional gel filtration standards (Sigma Chemical Co.) as well as puri- 
fied ezrin monomers and dimers (Bretscher et al., 1996). Blue dextran was 
used to determine the void volume. 
A431 cells were stimulated with EGF for 0, 1, and 3 min, followed by 
extraction  in  the  same buffer  used  for  placental  microvilli  containing 
phosphatase inhibitors: 200 p,M sodium orthovanadate, 30 IxM phenylar- 
sine oxide, 50 mM sodium fluoride, 50 mM ~3-glycerophosphate. Samples 
were chromatographed as described above in the presence of 100 ~M so- 
dium orthovanadate. 
To quantitate the relative amounts of monomeric and oligomeric forms 
of ezrin in extracts of A431 cells or placental microvilli, gel filtration frac- 
tions from representative experiments were pooled and adjusted to equal 
final volumes. The pooled fractions were then diluted serially and ana- 
lyzed by Western blotting. A  similar comparison was done for the oligo- 
met-containing fractions of extracts  from A431  cells  treated  with  and 
without EGF. 
Chemical Cross-linking 
Dithiobis-succinimidyl-propionate (DSP)  (Pierce  Chemical  Co.,  Rock- 
ford, IL), a homobifunctional thiol-cleavable cross-linker, was dissolved in 
dimethylformamide; in all experiments the final concentration of dimeth- 
ylformamide was less than 5%. 
Microvillus extracts were  subjected to gel filtration chromatography, 
and aliquots from each fraction were  incubated with or without 1 mM 
DSP for 45 min on ice. The reactions were stopped by boiling in Laemmli 
sample buffer under nonreducing conditions. 
A431 cells were stimulated with EGF for various times, followed by ex- 
traction with 1% Triton X-100, 100 mM NaCl, 20 mM Hepes, pH 7.4,  2 
mM EDTA, protease inhibitors, and phosphatase inhibitors. After cen- 
trifugation, the soluble extracts were incubated with or without 0.2 mM 
DSP for 45 min on ice. The reactions were either stopped as described 
above or were quenched by the addition of 1/20 volume of 1 M Tris, 1 M 
glycine, pH 6.8,  and subjected to  immunoprecipitation with ezrin anti- 
body. 
Purification  of Ezrin from Placental MicroviUi 
Microvilli (5 mg) were pelleted by centrifugation and extracted with 2% 
Triton X-100, 0.6 M KC1, 10 mM Hepes, pH 7.4, 2 mM EDTA, and pro- 
tease inhibitors. The extract was clarified by centrifugation at 100,000  g 
for 20 min, diluted with 5 vol of 75 mM KH2PO4, pH 7.2, and applied to a 
10  ml  hydroxyapatite  column  (HA-Ultrogel,  LKB  Instruments,  Inc., 
Gaithersburg, MD) equilibrated with 0.1  M phosphate, pH 7.2.  The col- 
umn was washed and eluted with a 50 ml linear gradient of 100-800 mM 
potassium phosphate, pH 7.2. Fractions were monitored by SDS-PAGE 
on 10% minigels and fractions rich in ezrin pooled and dialyzed against 20 
mM NaC1, 20 mM MES, pH 6.7. The material was then applied to a Mono 
S FPLC column (Pharmacia Fine Chemicals) and developed with a 40 ml 
gradient in this buffer with 20-1,000 mM NaCl. The peak ezrin-containing 
fractions were pooled  and dialyzed in 150  mM NaC1,  1 mM EDTA, 10 
mM Tris, pH 7.4, and then made 63% in ammonium sulfate. The precipi- 
tate was collected by centrifugation at 13,000 g for 15 min and immedi- 
ately dissolved in a minimal volume of 100 mM NaC1,  1 mM EDTA, 10 
mM Hepes, pH 7.4. The material was filtered and run on a Superose 6 HR 
10/30 column equilibrated with the same buffer. Fractions containing pure 
ezrin were  pooled,  cross-linked, and then analyzed by Coomassie blue 
staining, Western blotting, and mass spectroscopy. 
Mass Spectroscopy 
Ezrin purified from placental microvilli was cross-linked with 1 mM DSP, 
followed by the addition of 1/20 volume of 1 M glycine, 1 M Tris, pH 6.8 to 
quench the reaction. The material was dialyzed extensively against deion- 
ized water, lyophilized, and then redissolved in deionized water. The masses 
of the cross H-linked species were determined on a matrix-assisted laser 
desorption mass spectrometer (Mock et al., 1991; Wang and Chait, 1994). 
Results 
Ezrin Is a Major Protein of Isolated Placental Microvilli 
Human  placenta  is  known  to  be  a  rich  source  of ezrin 
(Bretscher,  1989) that is concentrated in the microvilli of 
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olution  immunoelectron  microscopy reveals  in  appropri- 
ately cut structures (Fig. 1 A, arrows), that ezrin is closely 
associated with the microvillus plasma membrane of these 
cells. Remarkably, ezrin is essentially absent from nonmi- 
crovillus regions of the apical plasma membrane, indicat- 
ing that in these and other polarized cells (Berryman et al., 
1993), ezrin is highly specific for actin-containing surface 
structures. 
Given the abundance and distribution of ezrin in placen- 
tal microvilli, we reasoned that these  structures  might be 
an excellent system for biochemical analysis of ezrin func- 
tion. We therefore purified placental microvilli using a mod- 
ification of established procedures (Booth et al., 1980), re- 
suiting in a  preparation  of microvilli that resembled  their 
counterparts  on intact cells.  By thin  section  electron  mi- 
croscopy, the  isolated  structures  appeared  as  right-side- 
out, spherical and elongated microvillus vesicles (Fig. 1 B). 
Contamination with other organelles was minimal: for ex- 
ample, very few nuclei or mitochondria were seen. Immu- 
noelectron microscopy revealed that >80% of the structures 
contained ezrin (Fig.  1 C).  In negative  stain preparations 
of glutaraldehyde-fixed microvilli, we observed a network 
of fine filaments within the interior of many structures, in- 
dicating that the integrity of the cytoskeleton was at least 
partially  preserved.  Negative  staining  also  revealed  the 
presence  of some clathrin coated vesicles, which was not 
surprising since placenta is a classic source for their purifi- 
cation (Pearse, 1982). 
SDS-PAGE analysis of the  overall composition of iso- 
lated  microvilli  (Fig. 2  A) showed a  reproducible,  simple 
polypeptide profile, in good agreement with earlier studies 
Figure 1.  Localization of ezrin in placental microvilli  in vivo and 
in vitro.  (A) Immunogold labeled (10-nm gold particles) section 
of intact human placental tissue.  Ezrin is highly concentrated in 
the microvilli  of the syncytiotrophoblast and is in close associa- 
tion with the plasma membrane in appropriately cut structures 
(arrows). (B) Ultrathin  section of isolated  placental  microvilli. 
The  preparation  typically consists  of elongated  and  spherical 
membrane-enclosed structures  with  amorphous or filamentous 
content. (C) Immunogold labeled (5-nm gold particles) section of 
isolated microvilli.  Ezrin is associated with nearly all of the iso- 
lated microvillus  structures. Bar, 1 Ixm. 
Figure 2.  Ezrin  is  a  major protein  of placental  microvilli.  Mi- 
crovilli were extracted with RIPA buffer and ultracentrifuged to 
give insoluble and soluble fractions.  The soluble fraction was de- 
pleted of ezrin by incubation with ezrin antiserum that had been 
pre-adsorbed to protein A-Sepharose beads.  The immunobeads 
were washed, and then eluted by boiling in Laemmli sample buffer. 
(A) Proteins from equal volumes of total microvilli, RIPA-insolu- 
ble and -soluble fractions, immunodepleted extract, and the cor- 
responding immunoprecipitate were resolved by SDS-PAGE on 
10% gels under reducing conditions and stained with Coomassie 
blue. The major 81-kD band in the RIPA-soluble fraction was re- 
moved quantitatively by immunoprecipitation with ezrin antibody. 
The volume of immunoprecipitate loaded on the gel represents 
5% of the total material eluted from the immunobeads. Actin (43 
kD) and a-actinin (105 kD) are seen as abundant proteins which 
are  relatively insoluble in RIPA buffer.  (B)  Equal volumes of 
RIPA-insoluble and -soluble fractions were diluted serially  (two- 
fold), run on SDS-PAGE, transferred to PVDF membranes, and 
then probed with ezrin antibody and peroxidase-conjugated pro- 
tein A. Similar concentrations of ezrin are seen in both fractions, 
indicating that ezrin accounts for most or all of the major 81-kD 
band seen in total microvillus  proteins. 
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Truman and Ford, 1986; Vanderpuye et al., 1986). Among 
the  most  abundant  polypeptide  components  are  several 
members of the annexin family of proteins (Edwards and 
Booth, 1987), actin, a 70-kD doublet, ezrin, and et-actinin 
(Vanderpuye et al., 1986). Treatment of the microvilli with 
RIPA buffer, which is often used to solubilize cells for im- 
munoprecipitation studies,  extracted surprisingly little  of 
the actin, about half of the ezrin, and little of the ct-actinin. 
The 81-kD band extracted by RIPA buffer was identified 
as ezrin because it could be removed quantitatively from 
the  extract  by immunoprecipitation  with  ezrin  antibody 
(Fig. 2 A). Since about half of the 81-kD polypeptide was 
extracted  from  these  structures  with  RIPA  buffer,  we 
questioned whether the 81-kD polypeptide in the residual 
insoluble material was also ezrin. Western blot analysis of 
serial dilutions of SDS-solubilized RIPA-soluble and RfPA- 
insoluble fractions showed that both contained about the 
same amount of ezrin polypeptide (Fig. 2 B).  Therefore, 
most, if not all, of the material at 81-kD is ezrin, of which 
about half can be extracted with RIPA buffer. By compar- 
ison with known amounts of purified protein, we estimate 
that ezrin comprises ~5 % of the total protein mass of iso- 
lated microvilli. The subunit molar abundance of actin/ezrin/ 
a-actinin,  as  determined  by  densitometry  of Coomassie 
blue-stained gels, was 10:2.4:1. 
Western blots of total microvillus proteins probed with 
antibodies specific for moesin (Franck et al., 1993)  and ra- 
dixin  (Fazioli  et  al.,  1993)  revealed  variable  but  minor 
amounts of these  related proteins. This was expected for 
moesin since it is enriched in stromal endothelial cells and 
not  the  syncytiotrophoblast (Berryman et al.,  1993).  The 
localization of radixin has not been reported in placenta, 
so the possibility that a small amount of the material in our 
preparations at ~81 kD is radixin cannot be excluded. 
Placental Microvilli Contain Multiple Covalent 
Ezrin Adducts 
In addition  to the  major 81-kD  ezrin band,  several poly- 
peptides with a mobility ranging from ~180-220-kD were 
recognized by affinity-purified ezrin antibody in Western 
blots of total microvillus proteins (Fig. 3 A). As compared 
with p81 ezrin, the high molecular weight species were ex- 
tracted poorly by RIPA buffer, suggesting a very tight as- 
sociation with  the  cytoskeleton.  We  refer collectively to 
these novel ezrin-immunoreactive species as covalent ad- 
ducts, because several criteria established that they contain 
the  ezrin polypeptide. First, the adducts were recognized 
specifically by three  different  ezrin  antibodies,  including 
the anti-peptide monoclonal Z036. A  banding pattern sim- 
ilar to the Western blot in Fig. 3 A  is representative of the 
species seen in a number of different microvillus prepara- 
tions. No significant qualitative or quantitative changes in 
this  banding  pattern  were  apparent  after storage  of mi- 
crovilli for two weeks on ice, ten freeze-thaw cycles before 
or after boiling in Laemmli buffer, increasing the concen- 
tration of reducing agent, or boiling for various times (0- 
180 s) in Laemmli buffer. Although the individual adduct 
species appeared minor in abundance relative to the major 
81-kD ezrin band, and were difficult to see on stained gels, 
collectively they  represented  a  significant  proportion  of 
Figure 3.  Identification  of covalent  ezrin adducts.  Proteins from 
the immunodepletion experiment were boiled in Laemmli sample 
buffer under reducing  conditions,  run on 8%  gels (15%  of the 
sample volumes used in Fig. 2 A), and transferred to PVDF mem- 
branes. The blots were probed with either ezrin antibody (A) or 
biotinyl-ezrin  (B) followed by the appropriate peroxidase-conju- 
gated  secondary  reagent,  and  then  were  developed  with  en- 
hanced chemiluminescence.  In addition  to the major 81-kD ezrin 
band, a series of high molecular weight bands (,-o180-220 kD) is 
seen in extracts  of total microvilli. Although the high molecular 
weight bands vary in intensity between the Western blot and the 
blot overlay, comparison of different exposures showed that each 
band  that stained  with  ezrin  antibody also  reacted in  the blot 
overlay. Note that the individual adducts are minor in abundance 
relative  to the major 81-kD ezrin band.  In addition,  the adducts 
are relatively  insoluble  in  RIPA buffer compared with  81-kD 
ezrin. Longer exposures were required to reveal the presence of 
adducts in the immunoprecipitate (IP) and quantitative depletion 
of adducts from the RIPA-soluble fraction (not shown). 
the total population of ezrin-immunoreactive species. Sec- 
ond,  the  small  amount  of adducts  solubilized  by RIPA 
buffer were precipitated by ezrin antibody (Fig. 3 A, lane 
IP*). Third, p81 and the adduct bands were recognized di- 
rectly by biotinylated ezrin in blot overlays (Fig. 3 B). Ear- 
lier work has shown that ezrin specifically interacts with it- 
self and  other ERM family members in  this  assay (Gary 
and Bretscher, 1993).  Although the relative staining inten- 
sity varied among individual  adducts both within and be- 
tween the two blotting methods we used (compare Total in 
Fig. 3, A  and B), analysis of Western blots and blot over- 
lays exposed for various times revealed identical banding 
patterns comprised of up to twelve distinct adduct species. 
The specificity of the blot overlay was confirmed by inclu- 
sion of excess unlabeled purified ezrin to compete with bi- 
otinyl-ezrin binding sites on the blot, resulting in a loss of 
adduct staining and a decreased signal at 81 kD. 
Ezrin Is a Component of the 
Detergent-insoluble Cytoskeleton 
Extraction of microvilli with 1% Triton X-100 under phys- 
iological salt conditions to yield classic cytoskeletons showed 
that ~50% of the total ezrin at 81 kD was associated with 
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seen in extracts prepared with RIPA buffer (Fig. 3 A). The 
adducts were even more resistant to extraction under these 
conditions (~80% insoluble), suggesting a tighter associa- 
tion with the cytoskeleton. The 81-kD ezrin and the adducts 
both  remained  completely insoluble  when  cytoskeletons 
were extracted under low salt (10 mM KC1) conditions, and 
only minor amounts were extracted by millimolar concen- 
trations of divalent cations (data not shown). Extraction of 
cytoskeletons with 1 M KC1 solubilized ~75% of the 81-kD 
ezrin and a  small proportion of the adducts.  The adducts 
required extraction with 6 M  urea to achieve greater than 
50% solubility. 
In  addition  to  ezrin,  the  detergent-insoluble  material 
was enriched in the cytoskeletal markers actin and et-acti- 
nin (Fig. 4 A). The lectin blot in Fig. 4 C shows that the de- 
tergent-soluble fraction was highly enriched in membrane 
glycoproteins,  demonstrating  that  efficient  solubilization 
of membrane proteins  was  achieved  under  these  condi- 
tions. 
Ezrin Exists Primarily As Noncovalent Oligomers in 
Placental Microvilli 
We  recently described  the  purification  and  characteriza- 
tion of ezrin monomers and noncovalent dimers from hu- 
man placenta (Bretscher et al., 1996).  To determine which 
species  are  present  in  placental  microvilli,  we  analyzed 
high salt detergent  extracts of microvilli by gel filtration 
Figure 4.  Ezrin is a major component of the detergent-insoluble 
cytoskeleton.  Microvilli were  extracted  with  Triton  X-100  at  a 
protein/detergent mass ratio of 1:10 to prepare detergent-insolu- 
ble  and  -soluble  fractions,  representing  cytoskeletal  and  mem- 
brane fractions, respectively.  After centrifugation and washing, 
equal  volumes  of the  detergent-insoluble pellet  (P)  and  deter- 
gent-soluble supernatant (S) were boiled in Laemmli buffer un- 
der reducing conditions, and then run on 8%  SDS-PAGE either 
individually, or as a mixture to yield total proteins (T). Gels were 
either stained with Coomassie  blue  (A), or were  transferred to 
PVDF membranes and then probed with ezrin antibody (B), or 
concanavalin A  (C). The Western blot shows that approximately 
half of the  81-kD  ezrin  band  is  associated  with  the  detergent- 
insoluble pellet whereas the ezrin adducts are preferentially asso- 
ciated with this fraction. In addition to ezrin, actin, and a-actinin 
are seen as major proteins of the Triton X-100-insoluble mate- 
rial.  The  lectin  blot  shows  that  the  extraction  conditions  em- 
ployed effectively solubilized the concanavalin A-binding glyco- 
proteins of the microvillus membrane. 
chromatography on a  Superose 6 column previously cali- 
brated  with  conventional  standards  as  well  as  purified 
ezrin  monomers  (Stokes  radius  41.~,) and  dimers  (72_A). 
Under these extraction conditions, ~70% of the ezrin was 
solubilized (Fig. 5 A, lanes P  and S). As shown in the Coo- 
massie blue-stained gel and Western blot in Fig. 5, A  and 
B, ezrin exhibited an unusually broad elution profile com- 
pared with other proteins, and was resolved into two peaks 
corresponding  to the  monomer (M; fractions 35-37) and 
the  dimer (D;  fractions 31-32). A  substantial  amount of 
ezrin eluted ahead of the dimer (fractions 25-30), perhaps 
reflecting higher order ezrin oligomers. Evidence to sup- 
port this notion is presented in Fig. 5  C.  We have shown 
previously by SDS-PAGE  that  chemical cross-linking of 
purified ezrin monomers and dimers yields broad bands at 
~81 and ~180 kD, respectively (Bretscher et al., 1996).  In 
Western  blots  of fractions  subjected  to  chemical  cross- 
linking  with  DSP,  we  observed  several  high  molecular 
weight bands, each of which exhibited a characteristic mo- 
bility during SDS-PAGE that correlated well with its rela- 
tive position of elution during chromatography. The rela- 
tive  mobilities  of  the  cross-linked  monomer  and  dimer 
were  identical  to  that  seen  with  the  purified  proteins 
(Bretscher et al., 1996).  At least two additional higher or- 
der oligomeric species were resolved both by gel filtration 
(fractions  25-30)  and  SDS-PAGE  of cross-linked  ezrin. 
The Stokes radius of the putative trimer was determined 
to be 85A.  Quantitative  analysis revealed that the  oligo- 
mers  (dimer and  higher)  account  for ~70%  of the  total 
ezrin mass in  the  microvillus extract.  These noncovalent 
oligomers are  remarkably stable  in  high  salt:  extracts of 
microvillus cytoskeletons prepared and chromatographed 
in the presence of 2 M KC1 yielded results similar to those 
shown in Fig. 5.  However, all the  noncovalent oligomers 
were completely reduced to monomers in microvillus ex- 
tracts  prepared  and  fractionated  by gel  filtration  in  the 
presence of 4 M urea. 
To determine whether or not the ezrin-containing bands 
generated by cross-linking consist entirely of ezrin, we pu- 
rified ezrin from placental microvilli by sequential  chro- 
matography on hydroxyapatite and Mono S cation exchange 
resins, ammonium sulfate fractionation, and gel filtration. 
The purified ezrin migrated as a single 81-kD band in Coo- 
massie blue-stained  gels  (Fig.  6 A)  under  both reducing 
and nonreducing conditions. As expected, cross-linking of 
purified  ezrin  with  DSP  yielded  two  broad  bands  corre- 
sponding  to  the  relative  mobilities  of cross-linked  ezrin 
monomer and dimer (Fig. 6 B). The masses of the purified 
cross-linked monomer and dimer, as determined by mass 
spectroscopy,  were  71,162  and  141,789  D,  respectively, 
consistent  with  the  predicted  molecular  masses  of  these 
species  after  chemical  modification  (Gould  et  al.,  1989; 
Bretscher  et  al.,  1996).  Although  at  least  two additional 
high  molecular  weight  bands  were  detected  with  longer 
exposures  of the  blot  shown  in  Fig.  6  B,  the  masses of 
these higher order oligomers were not determined due to 
insufficient quantities. 
EGF Stimulates the Formation of Ezrin 
Oligomers In Vivo 
Since placental microvilli contain  abundant  ezrin dimers, 
we  reasoned  that  stimulation  of  A431  cells  with  EGF, 
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ezrin oligomers by gel filtration chromatog- 
raphy and chemical cross-linking. Microvilli 
were  extracted with buffer containing 1% 
Triton X-100,  0.6 M  KCI, and protease in- 
hibitors, followed by centrifugation to yield 
an insoluble pellet (P) and soluble superna- 
tant (S). The supernatant, which contained 
~70%  of total ezrin, was then fractionated 
on a  Superose 6 gel filtration column. Ali- 
quots from fractions 18-42 were  boiled in 
Laemmli sample buffer under reducing con- 
ditions.  Proteins  were  resolved  by  SDS- 
PAGE on 8%  gels and either stained with 
Coomassie  blue  (A),  or  transferred  to 
PVDF  membranes  and  probed  with  ezrin 
antibody (B). The broad elution profile of 
ezrin is unique  compared with  other pro- 
teins. Two peaks are seen which correspond 
to the dimeric (D; fractions 31-32) and mo- 
nomeric (M; fractions 35-37) forms of ezrin, 
as determined by calibration of the column 
with purified ezrin dimers and  monomers. 
Note that a-actinin, a dimer having a Stokes 
radius of 77A  (Suzuki et  al., 1976),  elutes 
immediately before the ezrin dimer, which 
has a Stokes radius of 72,~ (Bretscher et al., 
1996). The existence of higher order oligo- 
mers is suggested by the substantial amount 
of the ezrin seen in fractions 25-30. The col- 
umn  void volume  emerges  in  fraction  18. 
Samples  from  fractions  18-42  were  sub- 
jected to cross-linking with DSP, run on 6% 
SDS-PAGE under nonreducing conditions, 
transferred  to  PVDF  membranes,  and 
probed with ezrin antibody (C). Cross-link- 
ing caused shifts in the migration of the var- 
ious ezrin species during SDS-PAGE which correspond well with their elution profile across fractions 25-37.  Broad bands are seen 
which correspond to the monomer, dimer, and higher order ezrin oligomers. The putative trimer (*) has a Stokes radius of 85A. 
which induces microvillus formation, might result in an in- 
crease in the proportion of ezrin dimers in vivo. Although 
about half of the ezrin in A431 cells is cytoskeletally asso- 
ciated  when  they  are  prepared  under  very gentle  condi- 
tions  (Gould et  al., 1986),  >95%  of the  ezrin can be ex- 
tracted when  cells are solubilized with TritonX-100  and 
0.6  M  KC1  (Fig. 7  A).  High  salt detergent  extracts from 
cells treated with or without EGF were fractionated by gel 
filtration and analyzed by Western blotting (Fig. 7  B). In 
contrast to placental microvilli, ~95%  of the ezrin in un- 
stimulated  A431  cell extracts was  monomeric.  However, 
about a  twofold increase in the amount of ezrin migrating 
at the position of the dimer was seen in extracts prepared 
just two minutes after stimulation with EGF. 
To determine the relationship between phosphorylation 
of ezrin on tyrosine and oligomer formation as a  function 
of time after EGF treatment, we devised an assay in which 
cell extracts were subjected to chemical cross-linking with 
a  relatively low concentration of DSP and then  analyzed 
by Western blotting. As shown  in Fig. 8 A, cross-linking 
resulted  in  the  appearance  of  a  high  molecular  weight 
ezrin species which increased in abundance  within  1  min 
after addition of EGF; no further increase was seen with 4 
or 10 min of EGF treatment. This result is consistent with 
the rapid formation of ezrin dimers described in Fig. 7 B. 
In Fig. 8 A, the cross-linked dimer has an apparent mobil- 
ity in excess of 180 kD; however, we have found that the 
apparent mobility of this species is sensitive to the acryl- 
amide concentration. Although it is difficult to prove that 
the cross-linked species seen in Fig. 8 A  actually represents 
ezrin dimers, they were found to migrate with a  mobility 
characteristic of a  cross-linked dimer.  In the  same  assay, 
ezrin was seen as a  major EGF-induced phosphotyrosine- 
containing band in blots probed with phosphotyrosine an- 
tibody (Fig. 8  B).  The  identity of this 81-kD  phosphoty- 
rosine band as ezrin was confirmed by immunodepletion 
(data  not  shown)  and  immunoprecipitation  experiments 
(Fig. 8 C). 
The  correlation  between  EGF-induced  ezrin  tyrosine 
phosphorylation and oligomerization was extended through 
the use of a  tyrosine kinase inhibitor and a  tyrosine phos- 
phatase inhibitor (Fig. 9). Treatment of cells with tyrphos- 
tin AG1478, a potent inhibitor of the EGF receptor kinase 
(Fry et al., 1994; Osherov and Levitski, 1994; Ward et al., 
1994),  before  and  during  stimulation with  EGF,  blocked 
both tyrosine phosphorylation of ezrin and de novo forma- 
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microvilli.  (A) Purified microvillar ezrin was run on 10%  SDS- 
PAGE in the presence of reducing agent, and visualized  by Coo- 
massie blue staining.  Ezrin appears to be devoid of any major 
protein contaminants and migrates as a single band at 81 kD. (B) 
The sample shown in A  was run on 6%  SDS-PAGE in the ab- 
sence of reducing agent before and after cross-linking  with DSP, 
then transferred to a PVDF membrane and probed with ezrin an- 
tibody. The products of the cross-linking  reaction consist of two 
broad bands at ~81 and ~180 kD, corresponding to the mono- 
meric and dimeric forms of ezrin, respectively.  As expected, a sin- 
gle band is seen at 81 kD in the absence of cross-linking.  Equal 
amounts of protein were loaded for all three samples. 
tion of ezrin oligomers.  Conversely, incubation with phe- 
nylarsine oxide, a tyrosine phosphatase inhibitor, enhanced 
the  degree  of  ezrin  phosphorylation  and  increased  the 
amount of ezrin oligomer formed. Although the data sug- 
gest that tyrosine phosphorylation might be necessary for 
ezrin oligomerization, two lines of evidence show that this 
modification is not required for the maintenance of stable 
oligomers. First, the level of ezrin oligomer was essentially 
constant  from  1-10  min  of EGF  treatment  (Fig.  8  A), 
whereas the level of phosphotyrosine-containing ezrin de- 
clined within this time frame (Fig. 8 B). Second, no specific 
phosphotyrosine staining of ezrin was detected in Western 
blots  of  ezrin  immunoprecipitates  from  placental  mi- 
crovilli (~5 I~g ezrin loaded onto gel) (data not shown). 
Discussion 
In this report we have examined the molecular structure of 
ezrin in microvilli isolated from the placental syncytiotro- 
phoblast.  These microvilli were previously known to con- 
tain  ezrin,  based  on  Western  blotting  and  immunocy- 
tochemistry (Berryman et al., 1993). The protein composition 
of cytoskeletons from placental microvilli is quite distinct 
from that of the intestinal brush border (Bretscher,  1991), 
presumably reflecting differences in cytoskeletal architec- 
ture, morphology, and function between these two polar- 
ized epithelial  cell  types.  In isolated  intestinal  microvilli, 
where ezrin is a relatively minor constituent, the actin fila- 
ments are bundled together by fimbrin and villin, and this 
Figure 7.  Stimulation of A431 carcinoma cells with EGF induces 
the rapid formation of ezrin dimers.  (A) Unstimulated A431 cells 
were rinsed  with cold PBS, scraped into 0.6 M  KC1 extraction 
buffer, and separated into insoluble and soluble fractions by cen- 
trifugation. Fourfold serial dilutions of the two fractions (lanes 1-3) 
were  analyzed  on  Western  blots  probed  with  ezrin  antibody. 
Greater than 95% of the total ezrin was soluble.  (B) Soluble ex- 
tracts prepared from cells treated with or without EGF for 2 min 
were run separately on a Superose 6 column. Fractions were ana- 
lyzed by Western  blotting  with  ezrin  antibody.  Peak  fractions 
representing  the  position of the  dimer  (D)  and  monomer (M) 
forms of ezrin are indicated. Although the same amount of ezrin 
was loaded onto the column (L) for both extracts, a significant in- 
crease in the amount of ezrin dimer is seen in extracts from EGF- 
stimulated cells. 
bundle  is  attached  laterally  to  the  plasma  membrane  by 
brush border myosin I  (Bretscher,  1991).  In contrast, iso- 
lated  placental  microvilli  lack  fimbrin  and  villin,  but  do 
contain  a-actinin  and  ezrin  as  two major components  of 
their actin-based cytoskeletons. Structurally, the intestinal 
brush border is characterized by densely packed microvilli 
of uniform size and shape, which have a highly ordered mi- 
crofilament core bundle that inserts into a well-structured 
terminal  web.  In contrast,  the  syncytiotrophoblast  brush 
border  displays  less  dense  packing  of  microvilli,  which 
vary in size and shape and are often bridged by clathrin- 
coated pits  at their  bases,  and whose apparently disorga- 
nized cytoskeletons are supported by a  loosely organized 
terminal web. These ultrastructural features correlate with 
the  relatively  high  rates  of endocytic uptake  and  mem- 
brane recycling at the apical surface of the syncytiotropho- 
blast.  Our  immunoelectron  microscopy  studies  reveal  a 
high concentration and close association of ezrin with the 
microvillus plasma membrane, but little or none in coated 
pits or other invaginations of the apical membrane. These 
observations are consistent with the proposed membrane- 
cytoskeletal linking function of ezrin, and also suggest the 
possibility that ezrin may serve a tethering role which lim- 
its or prevents the diffusion of certain resident membrane 
proteins into coated pits, thereby helping to maintain cell 
polarity. 
We have demonstrated that ezrin is highly abundant  in 
placental microvilli, and that much of it is associated with 
the  cytoskeleton.  Extraction  of placental  microvilli  with 
detergent  and physiologically relevant  buffers resulted  in 
the  solubilization  of about  half  the  ezrin  together  with 
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between the onset of ezrin oligomer formation and the phospho- 
rylation of ezrin on tyrosine. A431 cells were treated with EGF 
for various times (0, 1, 4, and 10 min) and scraped into solubiliza- 
tion buffer. After centrifugation to remove insoluble material, the 
extracts were subjected to cross-linking  with DSP, and the prod- 
ucts of the reaction resolved by 7 % SDS-PAGE under nonreduc- 
ing conditions. Proteins were transferred to PVDF membranes, 
and probed with either ezrin antibody (A)  or  anti-phosphoty- 
rosine antibody (B). As seen in A, the addition of cross-linking 
reagent resulted in the appearance of a high molecular weight 
ezrin species, which presumably represents the dimeric form re- 
solved by gel filtration in Fig. 7 B. This band increases in intensity 
within 1 min after addition of EGF and shows little further in- 
crease at 4 or 10 min. In B, uncross-linked  ezrin is seen as a major 
EGF-induced 81-kD phosphotyrosine-containing  protein in cells 
stimulated for 1 min with EGF. The level of tyrosine phosphory- 
lation of ezrin is maximal at 1 min and progressively decreases at 
4 and 10 min after growth factor treatment. The addition of DSP 
resulted in a correspondingly diminished phosphotyrosine signal 
at each  time point. Ezrin was  immunoprecipitated from cross- 
linked extracts and analyzed on a Western blot probed with phos- 
photyrosine antibody (C).  The time course of phosphotyrosine 
staining of 81-kD ezrin parallels what is seen in total extracts in B. 
some  of  the  ~t-actinin and  actin.  Increasing amounts of 
ezrin and other cytoskeletal components could be titrated 
from the cytoskeletons with increasing salt concentrations. 
Surprisingly, ~10% of the ezrin, and a significant propor- 
tion of the actin, was resistant to extraction even by 2 M 
KC1.  Gel filtration analysis of intact microvilli solubilized 
by 0.6 M  KC1 or of cytoskeletons extracted with 2 M  KC1 
gave similar ezrin elution profiles with the bulk of the ezrin 
migrating as oligomers, while most of the actin eluted as a 
monomer and ~t-actinin as an homogeneous dimer. In con- 
trast, in 4 M urea, all the ezrin eluted as a monomeric spe- 
cies yet the ~-actinin still remained a dimer. These obser- 
vations show that much of the ezrin is very tightly associated 
Figure 9.  EGF-induced ezrin oligomerization is inhibited by tyr- 
phostin AG1478 and enhanced by phenylarsine oxide.  Serum- 
starved A431 cells were stimulated with EGF for 0 (lanes 1 and 5) 
or 1 rain (lanes 2-4 and lanes 6-8). Tyrphostin AG1478 was used 
at 2.5 txM to inhibit the EGF receptor kinase and was present in 
the medium for 3 h before and during treatment with EGF (lanes 
3 and 7). Phenylarsine oxide was used at 30 txM to inhibit tyrosine 
phosphatase activity and was present for 30 rain before and dur- 
ing growth factor treatment (lanes 4 and 8). Cells were scraped into 
solubilization buffer, centrifuged,  and cross-linked with DSP. The 
cross-linked  extracts  were quenched, and then either boiled in 
Laemmli sample buffer (lanes 1-4) or subjected to immunopre- 
cipitation with ezrin antibody (lanes 5-8). A mock immunopre- 
cipitate was prepared in the absence of cell extract to control for 
background antibody staining (lane 9). Proteins were run on 7% 
SDS-PAGE under nonreducing  conditions, transferred to PVDF 
membranes, and probed with either phosphotyrosine antibody 
(A) or ezrin antibody (B). As shown in A, the relative amounts of 
phosphotyrosine staining of 81-kD ezrin in both the total cross- 
linked extracts (lanes 1-4) and the immunoprecipitates (lanes 
5-8) corresponds well with the overall levels of phosphotyrosine 
staining of other proteins in the extracts,  including the EGF re- 
ceptor. Note that treatment of cells with PAO resulted in the ap- 
pearance of a high molecular weight phosphotyrosine-containing 
band in the ezrin immunoprecipitate that exhibits the same mo- 
bility as the cross-linked ezrin dimer (lane 8, arrow). In B, the bulk 
of the ezrin migrated at 81 kD in each of the extracts.  However, 
the relative amounts of cross-linked dimer formed (D, arrows) 
correlate positively with the levels of tyrosine phosphorylation of 
ezrin seen in A. 
with the cytoskeleton, and that the extracted material con- 
tains multiple ezrin species. 
An unanticipated finding was that the bulk of the ezrin 
extracted from placental microvilli exists as  dimeric and 
higher  oligomeric forms.  It  seems  reasonable to  predict 
that the assembly hierarchy of the oligomers is monomers 
to dimers, to trimers, to tetramers, etc. This prediction is 
based  on  the  physical properties  of  purified monomers 
and dimers, and the existence of exclusively complemen- 
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as N-ERMADs and C-ERMADs (Bretscher et al.,  1996; 
Gary and Bretscher, 1995). The interactions that stabilize 
the dimer likely involve the association of the N-ERMAD 
of one molecule with the C-ERMAD of a second subunit. 
Since  the  C-ERMAD  is  masked  in  soluble  monomeric 
ezrin,  thereby precluding dimer formation, some regula- 
tory step must be required to activate or otherwise expose 
this domain to form a dimer (Gary and Bretscher, 1996). 
Because the dimer also has a masked C-ERMAD (Bretscher 
et al., 1996), we hypothesize that multiple activation events 
are required for the formation of trimers and higher order 
structures. These monomers, dimers, trimers, etc. that we 
can  extract  from placental  microvilli in  vitro  apparently 
represent distinct and stable ezrin populations that coexist 
in vivo. 
In  addition  to  these  noncovalent oligomers,  placental 
microvilli contain a minor, yet perhaps significant, popula- 
tion of covalently cross-linked ezrin species. A  plausible 
explanation  for their  existence  is  that  noncovalent ezrin 
oligomers are converted into covalent adducts by some en- 
dogenous cross-linking activity (e.g.,  a  transglutaminase). 
This cross-linking presumably occurs in vivo, since the ad- 
ducts did not increase in abundance after prolonged stor- 
age of isolated microvilli for up to two weeks on ice or af- 
ter incubation at 37°C for 30 min, nor do they appear to be 
artifacts induced by sample preparation. The variable mo- 
bility of the adducts during SDS-PAGE may result from 
the introduction of topologically different cross-links,  or the 
cross-linking of ezrin to some other protein. Although mi- 
nor, and  therefore technically difficult to work with, the 
adducts might be of considerable importance as they are 
much more tightly associated with the microvillus cytoskel- 
eton than the rest of the ezrin. 
Since  the  discovery  of  ezrin  (Bretscher,  1983),  there 
have been a number of puzzling findings surrounding the 
study  of this  microfilament-associated protein.  First,  al- 
though apparently a cytoskeletal molecule, ezrin is gener- 
ally very easy to extract  from cultured  cells  and  tissues 
(Bretscher,  1983,  1989;  Narvanen,  1985;  Hanzel  et  al., 
1991).  However, our results show that ezrin behaves as a 
bona  fide  cytoskeletal  protein  in  isolated  placental  mi- 
crovilli,  since  cytoskeletally  associated  ezrin  remained 
largely insoluble over a wide range of salt concentrations. 
Second, although the native intact molecule binds poorly 
to F-actin in vitro (Bretscher,  1983), Algrain et al. (1993) 
have nevertheless demonstrated that the COOH-terminal 
half of ezrin has  the  capacity to interact  with F-actin in 
vivo. Furthermore, two independent laboratories have re- 
cently shown that the  COOH-terminal region of ezrin is 
capable  of  direct  association  with  F-actin  in  vitro  (Tu- 
runen et al.,  1994; Pestonjamasp et al.,  1995). Third, puri- 
fied ezrin monomers and dimers can coexist as stable inde- 
pendent populations and show little  or no subunit exchange 
in vitro (Bretscher et al.,  1996).  Recent results from our 
laboratory have provided evidence that the F-actin bind- 
ing domain, which is contained within the C-ERMAD, is in- 
accessible in the native ezrin monomer (Gary and Bretscher, 
1995). Thus, it appears that the intermolecular interactions 
which govern F-actin binding and ezrin oligomerization are 
both subject to regulatory controls that affect the confor- 
mation of the C-ERMAD. This notion is further supported 
by studies in which ectopic expression of the COOH- and 
NH2-terminal  halves,  but  not  full-length  ERM  proteins, 
produce distinct morphogenetic effects in transfected cells 
(Algrain et al., 1993; Martin et al., 1995; Henry et al., 1995). 
How can we account for all these diverse findings to ex- 
plain the different structural forms of ezrin found in vivo 
and relate them to function? As shown in the schematic di- 
agram in Fig. 10, our hypothesis starts with the idea that a 
dormant form of monomeric ezrin exists  in the cytoplasm; 
in many cultured cell lines this may represent the bulk of 
the  ezrin present.  In response  to a  signal to remodel its 
cortical  cytoskeleton  to  form  actin-containing  surface 
structures,  dormant ezrin becomes activated,  perhaps  by 
some localized membrane-associated activator. Two types 
of activation can be envisaged: unmasking of the C-ERMAD 
for association with the N-ERMAD of another molecule 
to induce oligomerization, or unmasking of the  COOH- 
terminal domain to reveal the F-actin binding site. The re- 
lationship  between these two types of unmasking events 
remains to be determined.  Once bound to F-actin, ezrin 
binds tenaciously, thus explaining its tight association with 
F-actin in placental microvilli and its ability to bind F-actin 
in overlay assays (Pestonjamasp et al.,  1995).  In addition 
to F-actin  binding,  ezrin  must  be  able  to  associate  with 
some membrane protein, either as a result of concomitant 
unmasking of an  appropriate site,  or possibly by the  en- 
hanced avidity afforded by the multivalency of the oligo- 
meric species. Although the membrane binding partner of 
placental ezrin is currently unknown, Tsukita et al. (1994) 
Figure 10.  Speculative model for the involvement of ezrin and re- 
lated molecules (ERM proteins) in the assembly of cell surface 
structures.  It is  envisaged that  a  pool  of dormant  monomeric 
ezrin, containing a  masked  F-actin binding site and  a  masked 
C-ERMAD (C), exists free in the cytoplasm. An activation step, 
perhaps mediated  locally by some membrane-associated  factor, 
acts on monomeric ezrin to unmask the C-ERMAD for oligomer 
formation  through  association with an  N-ERMAD (N)  of an- 
other molecule, or to unmask the F-actin binding site. This may 
require additional activation steps because purified ezrin dimers 
also have masked C-ERMADs and F-actin binding sites (Bretscher 
et al., 1996). Evidence for stimulated oligomer formation is pre- 
sented in this paper. At some stage the ezrin molecules (here de- 
picted as trimers, but likely a mixture of various oligomeric spe- 
cies) associate with the  membrane.  Introduction  of an  F-actin 
cross-linker (such as a-actinin), will naturally drive the formation 
of a microvillus. In this scenario, ezrin oligomers will be found 
preferentially in surface structures, as reported here. 
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tor CD44  as  a  membrane  receptor for ERM proteins  in 
some cells; however this does not appear to be relevant to 
placental microvilli because they apparently lack this pro- 
tein  (our  unpublished  observations;  St.  Jacques  et  al., 
1993). Finally, additional proteins might be involved in the 
morphogenesis of microvilli such as the F-actin cross-link- 
ing protein depicted in Fig. 10. 
What might the ezrin activation process  be?  We  have 
demonstrated that treatment of A431  cells with EGF in- 
duces a rapid (<1 min) increase in tyrosine phosphoryla- 
tion of ezrin and in the formation of ezrin oligomers, sug- 
gesting that tyrosine phosphorylation and oligomerization 
might play a critical role in microvillus assembly. Although 
tyrosine  phosphorylation  may  represent  one  step  in  a 
pathway leading to ezrin oligomerization or F-actin bind- 
ing, our results indicate that stable  oligomers  can persist 
following a decrease  in tyrosine phosphorylation. It is in- 
teresting to note that ezrin also becomes phosphorylated 
on tyrosine in a variety of growth factor-stimulated  cells, 
virus-infected cells, and transformed cell lines (Bretscher, 
1989; Gould et al., 1986; Egerton et al., 1992; Fazioli et al., 
1993;  Kamps  et  al.,  1986; Thuillier  et  al.,  1994),  and on 
serine  and  threonine  in  stimulated  gastric  parietal  cells 
(Urushidani et al., 1989). In many of these cases, the phos- 
phorylation of ezrin correlates with the formation of ezrin- 
containing  surface  microvilli  or  membrane  ruffles.  The 
notion that phosphorylation of ezrin might regulate oligo- 
merization  is  now further  substantiated  by the  fact  that 
these  two  events  have  been  shown  to  occur  together 
within the  same  signal  transduction pathway. We  specu- 
late  that  activation  or  unmasking  of  the  C-ERMAD  in 
ezrin  monomers  allows  for  oligomer  formation,  F-actin 
binding, and membrane association to occur either simul- 
taneously or in rapid succession to generate microvilli. The 
challenge now is to determine what factors control oligo- 
mer formation and how this process is integrated into the 
circuitry that modulates the architecture of the cortical cy- 
toskeleton. 
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